Clinical Trial Update: Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the efficacy and safety of oral roflumilast compared with intralesional corticosteroid injections for alopecia areata.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: Cairo University | Conditions: Alopecia, Alopecia Areata | Phase 4 | Status: COMPLETED